Search

Displaying results 5921 - 5930 of 10000 in total
  1. Drug

    Secretin porcine

    go.drugbank.com/drugs/DB09527
    ApprovedWithdrawn

    Secretin porcine stimulates pancreatic and gastric secretions to aid in the diagnosis of pancreatic exocrine dysfunction and the diagnosis of gastrinoma.

  2. Drug

    Rhus Glabra Pollen

    go.drugbank.com/drugs/DB13895
    Approved

    The pollen is mainly used in allergenic testing.

  3. Drug

    Argan oil

    go.drugbank.com/drugs/DB14310
    Investigational

    Argan oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  4. Drug

    Macadamia oil

    go.drugbank.com/drugs/DB14330
    Investigational

    Macadamia oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  5. Drug

    Tribulus terrestris

    go.drugbank.com/drugs/DB14358
    Investigational

    Tribulus terrestris is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  6. Drug

    Ethylmercurithiosalicylic acid

    go.drugbank.com/drugs/DB02731
    Experimental

    Ethylmercurithiosalicylic acid is a topical antiseptic used on skin and mucous membranes. It is also used as a preservative in pharmaceuticals.

  7. Drug

    Besifloxacin

    go.drugbank.com/drugs/DB06771
    Approved

    FDA approved on May 28, 2009.

  8. Drug

    Chlormerodrin

    go.drugbank.com/drugs/DB00534
    ApprovedWithdrawn

    Chlormerodrin is a mercurial compound with toxic side effects that was previously used as a diuretic. The radiolabeled form has been used as a diagnostic and research tool. It is no longer used and has been replaced with new classes of d...

  9. Drug

    Bexotegrast

    go.drugbank.com/drugs/DB16515
    Investigational

    In addition, the compound is also currently in Phase 2a trials (NCT04565249) for the treatment of COVID-19 related acute respiratory distress syndrome[L31713]. … The compound was granted orphan drug designation by the US FDA in August 2018 for treatment of IPF, and Pliant Therapeutics recently raised $100 million in Series C financing to support further clinical

  10. Drug

    PPI-1019

    go.drugbank.com/drugs/DB05832
    Investigational

    Apan (PPI-1019) is developed by Praecis Pharmaceuticals to treat Alzheimer's Disease.